Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotechnology in transfusion medicine.

H H Sonneborn1

  • 1Biotest AG, Research Department, Dreieich, FRG.

Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1992
PubMed
Summary

Biotechnology, including monoclonal antibodies and genetic engineering, offers new transfusion possibilities. These advanced techniques are currently used and hold future potential in transfusion medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin.

The Journal of biological chemistry·2002
Same author

An antigen fragment encompassing the AD2 domains of glycoprotein B from two different strains is sufficient for differentiation of primary vs. recurrent human cytomegalovirus infection by ELISA.

Journal of medical virology·2001
Same author

A D(V)-like phenotype is obliterated by A226P in the partial D DBS.

Transfusion·2001
Same author

Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.

Clinical and diagnostic laboratory immunology·2001
Same author

Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.

Journal of medical virology·2001
Same author

Generation of monoclonal antibodies directed against the immunogenic glycoprotein K8.1 of human herpesvirus 8.

Hybridoma·2000

Area of Science:

  • Biotechnology
  • Immunology
  • Genetics

Background:

  • Traditional transfusion practices face evolving challenges.
  • Biotechnology offers novel solutions for blood product safety and efficacy.

Purpose of the Study:

  • To provide an overview of emerging biotechnologies in transfusion medicine.
  • To highlight current applications and future perspectives of these techniques.

Main Methods:

  • Review of scientific literature on biotechnology applications in transfusion.
  • Analysis of case examples demonstrating current use.

Main Results:

  • Monoclonal antibodies are utilized for improved diagnostics and therapeutics.
  • Genetic engineering enables enhanced production and modification of blood components.

Conclusions:

  • Biotechnology significantly expands the scope and capabilities of transfusion services.
  • Continued innovation in these areas promises further advancements in patient care.

Related Experiment Videos